Heptech Biotecnologia

Heptech is a company specialized in the heparin drug industry with expertise in academic, regulatory, industrial, and marketing areas. Our company focuses on quality control analysis, process improvement, and intermediary services for the pharmaceutical market's heparin commercialization, as well as research and development of innovative biological drugs for global introduction in the anticoagulant, oncological, and anti-inflammatory markets. Our pipeline's main products include: 1) a new, unfractionated bovine heparin (UFH) equivalent to the gold standard products of porcine origin; 2) the first low molecular weight bovine heparin (LMWH); and 3) a low anticoagulant bovine heparinoid for use as an anti-metastatic (oncological) and anti-inflammatory drug.